Effect of erythropoietin on Glasgow Coma Scale and Glasgow Outcome Scale in patient with diffuse axonal injury

Journal of Research in Medical Sciences

Volumn 17, Issue 1, 2012, Pages 51-56

  Abrishamkar, Saeid ^a   Safavi, Mohammadreza ^b   Honarmand, Azim ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diffuse axonal injury; Erythropoietin; Outcome

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGE; ARTICLE; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; DIFFUSE AXONAL INJURY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE COUNT; EXTUBATION; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HEMATOCRIT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTE COUNT;

EID: 84856756650     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C, et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A 2002; 99(14): 9450-5.
2. Feng D, Ma Y, Zhang Y, Plets C, Goffin J, Chen J. Controlled study of nimodipine in treatment of patients with diffuse axonal injury. Chin J Traumatol 2000; 3(2): 85-8.
3. Wolf JA, Stys PK, Lusardi T, Meaney D, Smith DH. Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci 2001; 21(6): 1923-30.
4. Siren AL, Knerlich F, Poser W, Gleiter CH, Bruck W, Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol 2001; 101(3): 271-6.
5. Yamamoto M, Koshimura K, Sohmiya M, Murakami Y, Kato Y. Effect of erythropoietin on nitric oxide production in the rat hippocampus using in vivo brain microdialysis. Neuroscience 2004; 128(1): 163-8.
6. Assandri R, Egger M, Gassmann M, Niggli E, Bauer C, Forster I, et al. Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line. J Physiol 1999; 516 (Pt 2): 343-52.
7. Tan CC, Eckardt KU, Ratcliffe PJ. Organ distribution of erythropoietin messenger RNA in normal and uremic rats. Kidney Int 1991; 40(1): 69-76.
8. Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, et al. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 1996; 8(4): 666-76.
9. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997; 76(1): 105-16.
10. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 1998; 95(8): 4635-40.
11. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999; 19(6): 643-51.
12. Fisher M, Schaebitz W. An overview of acute stroke therapy: past, present, and future. Arch Intern Med 2000; 160(21): 3196-206.
13. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22(9): 391-7.
14. Groswasser Z, Cohen M, Keren O. Female TBI patients recover better than males. Brain Inj 1998; 12(9): 805-8.
15. Kirkness CJ, Burr RL, Mitchell PH, Newell DW. Is there a sex difference in the course following traumatic brain injury? Biol Res Nurs 2004; 5(4): 299-310.
16. Mostafa G, Huynh T, Sing RF, Miles WS, Norton HJ, Thomason MH. Gender-related outcomes in trauma. J Trauma 2002; 53(3): 430-4.
17. Roof RL, Stein DG. Gender differences in Morris water maze performance depend on task parameters. Physiol Behav 1999; 68(1-2): 81-6.
18. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, et al. Erythropoietin crosses the bloodbrain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 2000; 97(19): 10526-31.
19. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NFkappaB signalling cascades. Nature 2001; 412(6847): 641-7.
20. Grasso G, Sfacteria A, Cerami A, Brines M. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist 2004; 10(2): 93-8.
21. Ozturk E, Demirbilek S, Kadir BA, Saricicek V, Gulec M, Akyol O, et al. Antioxidant properties of propofol and erythropoietin after closed head injury in rats. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29(6): 922-7.
22. Shein NA, Horowitz M, Alexandrovich AG, Tsenter J, Shohami E. Heat acclimation increases hypoxia-inducible factor 1alpha and erythropoietin receptor expression: implication for neuroprotection after closed head injury in mice. J Cereb Blood Flow Metab 2005; 25(11): 1456-65.
23. Siren AL, Radyushkin K, Boretius S, Kammer D, Riechers CC, Natt O, et al. Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain 2006; 129(Pt 2): 480-9.
24. Verdonck O, Lahrech H, Francony G, Carle O, Farion R, Van de Looij Y, et al. Erythropoietin protects from posttraumatic edema in the rat brain. J Cereb Blood Flow Metab 2007; 27(7): 1369-76.
25. Yatsiv I, Grigoriadis N, Simeonidou C, Stahel PF, Schmidt OI, Alexandrovitch AG, et al. Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J 2005; 19(12): 1701-3.
26. Kawakami M, Sekiguchi M, Sato K, Kozaki S, Takahashi M. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol Chem 2001; 276(42): 39469-75.
27. Grasso G. Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. J Neurosurg Sci 2001; 45(1): 7-14.
28. Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci U S A 2002; 99(4): 2258-63.
29. Shingo T, Sorokan ST, Shimazaki T, Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 2001; 21(24): 9733-43.
30. Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N, et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol 2000; 401(3): 349-56.
31. Bao H, Jacobs-Helber SM, Lawson AE, Penta K, Wickrema A, Sawyer ST. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood 1999; 93(11): 3757-73.